Powl Brian T. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$31,230.20

Insider Activity of Powl Brian T.

According to the SEC Form 4 filings, Powl Brian T., being in a position of

  1. Chief Commercial Officer at Kura Oncology, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 62435 shares for $663,417,
    over all time since 2025-01-28, has bought 0 shares, and sold 72909 shares for $755,383.

Biography of Powl Brian T.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $663,4177100

Comparison of Insiders on Amount of Buys and Sells

2026-09-29SaleKura Oncology, Inc.
KURA
Chief Commercial Officer
15,430
0.0173%
$10.75$165,852-7.64%
2026-09-28SaleKura Oncology, Inc.
KURA
Chief Commercial Officer
17,020
0.019%
$10.53$179,183-4.62%
2026-08-21SaleKura Oncology, Inc.
KURA
Chief Commercial Officer
4,345
0.0049%
$11.89$51,663-9.84%
2026-05-21SaleKura Oncology, Inc.
KURA
Chief Commercial Officer
10,000
0.0111%
$11.00$110,000-4.72%
2026-05-19SaleKura Oncology, Inc.
KURA
Chief Commercial Officer
339
0.0004%
$9.21$3,122+18.36%
2026-01-27SaleKura Oncology, Inc.
KURA
Chief Commercial Officer
6,414
0.0074%
$8.46$54,266+12.99%
2025-11-14SaleKura Oncology, Inc.
KURA
Chief Commercial Officer
8,887
0.0107%
$11.18$99,329-12.71%
2025-09-29SaleKura Oncology, Inc.
KURA
Chief Commercial Officer
8,891
0.0102%
$8.94$79,505+9.03%
2025-01-28SaleKura Oncology, Inc.
KURA
Chief Commercial Officer
1,583
0.0021%
$7.87$12,461+0.9%
2023-07-05SaleFate Therapeutics, Inc.
FATE
Chief Commercial Officer
3,854
0.0039%
$4.87$18,769-23.46%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.